by aisling | Jul 12, 2024 | News
Leiden, 12th July 2024 – ExCulture B.V., a biotechnology startup focused on the development of an animal-free heparin substitute via fermentation, is proud to share that it has closed its latest funding round with Capricorn Partners and TTT Medtech. The...
by Kenjiro Lolling | Apr 24, 2024 | News
On Friday 12th April 2024 ExCulture was announced as winner of the 2024 DSM-Firmenich Kickstart Prize, securing €50,000 after pitching to and addressing the questions of the experienced jury panel composed of Oscar Goddijnm Kirsten Herben-Steinbusch, Adam Burja and...
by Kenjiro Lolling | Mar 24, 2024 | News
Looking back on a successful first experience of the BioEurope Spring Conference held in Barcelona for ExCulture.We had the opportunity to make many new and foster existing connections in the fermentation, manufacturing, clinical and regulatory fields. We look forward...
by Kenjiro Lolling | Dec 30, 2023 | News
ExCulture has been selected as one of the top 20 Academic Startups in the Netherlands. After passing the initial selection round that consisted of pitching to a panel of experienced professionals in the Life Sciences sector, we will now embark on a tailored support...
by Kenjiro Lolling | Dec 10, 2023 | News
ExCulture has secured €350,000 from UNIIQ/Delft Enterprises. This substantial funding, combined with the support of UNIIQ will propel ExCulture further on our mission to develop an animal-free, alternative heparin. We are grateful to have the opportunity to contribute...
by Kenjiro Lolling | Dec 10, 2023 | News
Starting from December 2023 ExCulture has officially taken residence at Planet B.io in the Biotech Campus Delft. ExCulture believes that the mission of Planet B.io which is to “accelerate the transition to a sustainable, biobased, and circular society by establishing...
